Targeted Strategies for Today's Evolving Markets

MissionIR Blog

Monthly Archives: September 2015

iPass (IPAS) Presents at Rodman & Renshaw Conference

iPass, Inc. (NASDAQ: IPAS) is a global Wi-Fi roaming market leader for enterprise employees and service provider subscribers. The company knits the world’s commercial Wi-Fi networks together to create a single global Wi-Fi network. With the massive acceleration of the … Continue reading

Posted in Rodman and Renshaw Conference | Leave a comment

InVivo Therapeutics Holdings (NVIV) Presents at Rodman & Renshaw Conference

InVivo Therapeutics Holdings Corp. (NASDAQ: NVIV) is on a quest to redefine the life of the spinal cord injury patient. Armed with cutting-edge technology and MIT science, experienced business and medical professionals at InVivo Therapeutics are pushing the boundaries of … Continue reading

Posted in Rodman and Renshaw Conference | Leave a comment

Inventergy Global (INVT) Presents at Rodman & Renshaw Conference

Inventergy Global, Inc. (NASDAQ: INVT) is the brainchild of one of the intellectual property world’s most influential leaders, Joe Beyers. Having led global licensing for Hewlett-Packard for years, Beyers knew first-hand the challenges of leveraging IP assets for technology powerhouses. … Continue reading

Posted in Rodman and Renshaw Conference | Leave a comment

Inuvo (INUV) Presents at Rodman & Renshaw Conference

Inuvo, Inc. (NYSE: INUV) is an Internet marketing and technology company that delivers purchase-ready customers to advertisers through a broad network of desktop and mobile websites and app. The company has the opportunity to work with some pretty impressive powerhouses. … Continue reading

Posted in Rodman and Renshaw Conference | Leave a comment

International Stem Cell (ISCO) Presents at Rodman & Renshaw Conference

International Stem Cell Corporation (OTCQB: ISCO) is a Montreal-based company devoted to developing its novel and innovative proprietary technologies for enhanced drug delivery. Through its cutting edge formulation platforms, the company has developed a broad and diverse product portfolio, including … Continue reading

Posted in Rodman and Renshaw Conference | Leave a comment

IntelGenx (IGXT) Presents at Rodman & Renshaw Conference

IntelGenx (OTC: IGXT) is a drug delivery company focused on the development of oral controlled-release products as well as novel rapidly disintegrating delivery systems. The company’s unique multiple layer delivery system provides zero-order release of active drugs in the gastrointestinal … Continue reading

Posted in Rodman and Renshaw Conference | Leave a comment

InspireMD (NSPR) Presents at Rodman & Renshaw Conference

InspireMD, Inc. (NYSE: NSPR) was founded in 2005 with the purpose of creating a technology that could solve the problem of embolization in high risk vascular procedures. The company has grown to include a portfolio of embolic protection systems, which … Continue reading

Posted in Rodman and Renshaw Conference | Leave a comment

Inovio Pharmaceuticals (INO) Presents at Rodman & Renshaw Conference

Inovio Pharmaceuticals, Inc. (NASDAQ: INO) is on a quest to expand immune system stimulation to revolutionize the fight against cancers and infectious diseases. Stimulating the body’s immune system remains one of the most promising approaches to addressing the unmet needs … Continue reading

Posted in Rodman and Renshaw Conference | Leave a comment

Information Services Group (III) Presents at Rodman & Renshaw Conference

Information Services Group, Inc. (NASDAQ: III) is a leading technology insights, market intelligence and advisory services company, serving more than 500 clients around the world to help them achieve operational excellence. ISG supports private and public sector organizations to transform … Continue reading

Posted in Rodman and Renshaw Conference | Leave a comment

Immunomedics (IMMU) Presents at Rodman & Renshaw Conference

Immunomedics, Inc. (NASDAQ: IMMU) is committed to being a leading, innovative biopharmaceutical company dedicated to improving a patient’s health and quality of life with novel antibody–based therapeutics for the treatment of cancer, autoimmune and other serious diseases. The company’s work … Continue reading

Posted in Rodman and Renshaw Conference | Leave a comment